LARP6 and cancer: These results are complementary with recent findings, which have shown a link between EMT and enhanced rRNA transcription (Prakash et al., 2019), and highlight a potential therapeutic avenue, via LARP6 inhibition, for specific targeting of ribosome biogenesis in cancers with strong EMT features.